Zymeworks (ZYME) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Zymeworks Third Quarter 2024 Earnings: Revenues Disappoint
Yahoo FinanceNov 2 09:53 ET
Zymeworks Drops as Wells Fargo Cuts on Valuation
Seeking AlphaNov 1 11:20 ET
Zymeworks Down Over 8%, on Pace for Largest Percent Decrease Since December 2022 -- Data Talk
Dow JonesNov 1 11:06 ET
Express News | Zymeworks Shares Down 6.2% After Q3 Results
ReutersNov 1 09:31 ET
Zymeworks Inc. (NASDAQ:ZYME) Analysts Are Reducing Their Forecasts For Next Year
Yahoo FinanceNov 1 08:54 ET
Stifel Maintains Zymeworks(ZYME.US) With Buy Rating, Maintains Target Price $28
Moomoo NewsNov 1 08:31 ET · Ratings

Comments

Jaguar8

Jul 22 05:03

NEWS

$Zymeworks (ZYME.US)$
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
Zymeworks Inc. (Nasdaq: ZYME) announced FDA clearance of its Investigational New Drug (IND) application for ZW191, a novel folate receptor-⍺ (FR⍺) targeted topoisomerase I inhibitor antibody-drug conjugate (ADC). ZW191 targets FR⍺-expressing tumors, including ovarian, gynecological cancers, and non-small...

Jaguar8

Jun 17 06:42

NEWS

$Zymeworks (ZYME.US)$
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
Zymeworks (Nasdaq: ZYME) announced that the FDA has cleared its investigational new drug (IND) application for ZW171, a novel 2+1 T-cell targeting bispecific antibody designed to treat mesothelin (MSLN)-expressing cancers such as ovarian cancer, non-small cell lung cancer, and mesothelioma. ZW171 aims to i...

1